These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19555527)

  • 21. Tuberculosis treatment outcome and health services: a comparison of displaced and settled population groups in Khartoum, Sudan.
    Bøhler M; Mustafaa SA; Mørkve O
    Int J Tuberc Lung Dis; 2005 Jan; 9(1):32-6. PubMed ID: 15675547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand.
    Kapella BK; Anuwatnonthakate A; Komsakorn S; Moolphate S; Charusuntonsri P; Limsomboon P; Wattanaamornkiat W; Nateniyom S; Varma JK
    Int J Tuberc Lung Dis; 2009 Feb; 13(2):232-7. PubMed ID: 19146753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case finding for pulmonary tuberculosis, Queen Elizabeth Central Hospital, Blantyre, Malawi.
    Harries AD; Kamenya A; Schoevers MA; Boeree MJ; Nunn P; Salaniponi FM; Nyangulu DS
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):523-7. PubMed ID: 9487450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the quality of cohort analysis by incorporating treatment outcomes of 'transferred in' TB cases.
    Ottmani SE; Zignol M; Blanc L; Bencheikh N; Laâsri L; Mahjour J
    Int J Tuberc Lung Dis; 2007 May; 11(5):588-90. PubMed ID: 17439687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multidrug resistant tuberculosis in Iceland--case series and review of the literature].
    Asgeirsson H; Blöndal K; Blöndal T; Gottfredsson M
    Laeknabladid; 2009; 95(7-8):499-507. PubMed ID: 19553708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area.
    Schreiber YS; Herrera AF; Wilson D; Wallengren K; Draper R; Muller J; Dawood H; Doucette S; Cameron DW; Alvarez GG
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1274-80. PubMed ID: 19793433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges of tuberculosis control.
    Murray S
    CMAJ; 2006 Jan; 174(1):33-4. PubMed ID: 16389233
    [No Abstract]   [Full Text] [Related]  

  • 29. Tuberculosis case--finding and treatment in the central prison of Qazvin province, Islamic Republic of Iran.
    Assefzadeh M; Barghi RG; Shahidi ShS
    East Mediterr Health J; 2009; 15(2):258-63. PubMed ID: 19554970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical development of anti-tuberculosis drugs.
    Mitchison DA
    J Antimicrob Chemother; 2006 Sep; 58(3):494-5. PubMed ID: 16840430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notes from the field--TB control 'sound bites'.
    Menzies D
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):488-9. PubMed ID: 9487443
    [No Abstract]   [Full Text] [Related]  

  • 32. [Topical treatment of pulmonary and bronchial diseases at a district antituberculosis dispensary].
    Vdovichenko IA; Shcherbatiuk AS
    Probl Tuberk; 1973; 51(1):84-5. PubMed ID: 4727164
    [No Abstract]   [Full Text] [Related]  

  • 33. TB in disasters.
    Ford N; Sizaire V; Mills E
    Int J Tuberc Lung Dis; 2008 Oct; 12(10):1104. PubMed ID: 18812036
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug packaging: would 'blister packs' improve compliance and is 'one-box, one patient' of interest for TB control programmes?
    Trébucq A
    Int J Tuberc Lung Dis; 2003 Dec; 7(12):1211-2. PubMed ID: 14677901
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of treatment outcome in re-treatment versus new smear positive cases of tuberculosis under RNTCP.
    Pardeshi GS; Deshmukh D
    Indian J Public Health; 2007; 51(4):237-9. PubMed ID: 18232166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Formation of incentives to recovery and compliance of a chemotherapy regimen in patients with tuberculosis].
    Bogorodskaia EM; Danilova MD; Lomakina OB
    Probl Tuberk Bolezn Legk; 2007; (3):46-64. PubMed ID: 17500229
    [No Abstract]   [Full Text] [Related]  

  • 38. A step-wise approach to find a valid and feasible method to detect non-adherence to tuberculosis drugs.
    Ruslami R; van Crevel R; van de Berge E; Alisjahbana B; Aarnoutse RE
    Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):1083-7. PubMed ID: 19062699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis of the breast in an adolescent girl: a rare presentation.
    Indumathi CK; Alladi A; Dinakar C; Rout PL
    J Trop Pediatr; 2007 Apr; 53(2):133-4. PubMed ID: 17158811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of default from tuberculosis treatment: a systematic review.
    Kruk ME; Schwalbe NR; Aguiar CA
    Trop Med Int Health; 2008 May; 13(5):703-12. PubMed ID: 18266783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.